Mirati Therapeutics, Inc.

MetLife Investment Management, LLC

Report date

12/31/2023

Quarter

2023 Q4

Filed

4/22/2024

Shares

1,064

Value ($000)

63

Weight

0.0%

2018 Q3 - 2023 Q4 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	4/22/2024	63	0.0%	1,064	12/31/2023
2023 Q3	5/9/2024	39	0.0%	905	9/30/2023
2023 Q2	4/29/2024	33	0.0%	903	6/30/2023
2023 Q1	5/9/2024	34	0.0%	924	3/31/2023
2022 Q4	5/10/2024	42	0.0%	922	12/31/2022
2022 Q3	5/10/2024	62	0.0%	885	9/30/2022
2022 Q2	5/10/2024	61	0.0%	906	6/30/2022
2022 Q1	5/10/2024	197	0.0%	2,397	3/31/2022
2021 Q1	5/17/2024	2,734	0.0%	15,963	3/31/2021
2020 Q4	5/24/2024	3,736	0.0%	17,011	12/31/2020
2020 Q3	5/24/2024	2,596	0.0%	15,632	9/30/2020
2020 Q2	5/24/2024	1,847	0.0%	16,176	6/30/2020
2020 Q1	7/12/2023	973	0.0%	12,655	3/31/2020
2019 Q4	7/12/2023	1,545	0.0%	11,990	12/31/2019
2019 Q3	7/12/2023	934	0.0%	11,990	9/30/2019
2019 Q2	7/12/2023	1,158	0.0%	11,239	6/30/2019
2019 Q1	7/13/2023	702	0.0%	9,577	3/31/2019
2018 Q4	7/13/2023	365	0.0%	8,594	12/31/2018
2018 Q3	7/13/2023	405	0.0%	8,594	9/30/2018